Center for Global Health R&D Policy Assessment

Follow us on:

Save the Date: Webinar on alternative models for global health R&D

The business of developing drugs, vaccines, and diagnostics for neglected disease is complex. Public and private product developers must navigate tough scientific challenges, identify financing options, explore uncertain markets, and establish wide-ranging collaborations to come up with promising technologies.

Changing our definition of neglected diseases

Is it time to think beyond traditional terms?

Depending on who you ask, you’ll come up with a number of different definitions for what exactly characterizes a neglected disease, as there’s no generally accepted definition. I personally like the one offered by the NIH: “Global health organizations define neglected diseases as those that are prevalent among impoverished and marginalized populations in the developing world. Tropical environments, poor living conditions, and limited access to health care contribute to the risk and spread of these diseases.”*

Center Launches New Primer on Collaborative Health R&D

There’s a lot of buzz about the potential for collaborative approaches to R&D to speed up product development timelines, bring fresh ideas to the table, and cast more attention on diseases of the poor. But what is collaborative R&D exactly? Who’s doing it and why? Is open source the same as crowdsourcing?

The Center recently launched a web-based primer that is a starting point in answering some of these questions and laying out different approaches to collaborative R&D in health.

What do we need to address the global NCD epidemic?

Reflections from the event "The State of Global NCDs"

Shantanu Nundy speaking at the event

Last year, the Center for Global Health R&D Policy Assessment explored non-communicable diseases (NCDs) as it was coming out of the public health woodworks.

Save the Date: The State of Global NCDs

One year after the UN High Level Meeting on NCDs

The George Washington University Center for Global Health and the Results for Development Institute present:

The State of Global NCDs: One year after the UN High Level Meeting

One year following the September 2011 United Nations High Level Meeting on Noncommunicable Diseases, what has been accomplished? Join us and a panel of key experts to discuss progress, gaps, and priorities for advancing measurable progress against NCDs globally.

Monday, November 12, 2012
12:30 – 2:00 pm
The George Washington University

Center for Global Health

Insider Views of Collaborative R&D for Health: Q&A with Aled Edwards

Hassan Masum interviews the Director of the Structural Genomics Consortium as part of a series on collaborative R&D programs

Aled Edwards

Hassan Masum is the co-author of the Center’s report “Open Source for Neglected Diseases: Magic Bullet or Mirage?”

This is the eighth in a series of interviews by Hassan Masum of leaders of collaborative health R&D programs.

Save the Date: Research and Development for Global Health

The Contributions of Brazil, China, and India

The Center for Strategic and International Studies and the Results for Development Institute invite you to:

Research and Development for Global Health: The Contributions of Brazil, China, and India

Monday, November 5, 2012
10:00 am – 12:00pm (EST)
Center for Strategic and International Studies, B1 Conference Center
1800 K Street NW
Washington, D.C., 20006

Insider Views of Collaborative R&D for Health: Q&A with Leslie Chan

Hassan Masum interviews an open access pioneer as part of a series on collaborative R&D programs

Leslie Chan

Hassan Masum is the co-author of the Center’s report “Open Source for Neglected Diseases: Magic Bullet or Mirage?”

This is the seventh in a series of interviews by Hassan Masum of leaders of collaborative health R&D programs.

Optimism and the HIV/AIDS Epidemic

Recent biomedical advances in AIDS research have allowed political figures such as Secretary of State Hillary Clinton to proclaim that the phenomenon of a generation without HIV/AIDS is within reach. But how well-founded is this optimism?

Insider Views of Collaborative R&D for Health: Q&A with Matt Todd

Hassan Masum interviews an open drug development pioneer as part of a series on collaborative R&D programs

Matt Todd

Hassan Masum is the co-author of the Center’s report “Open Source for Neglected Diseases: Magic Bullet or Mirage?”

This is the sixth in a series of interviews by Hassan Masum of leaders of collaborative health R&D programs.